AbbVie’s $1.4B campus bet

AbbVie is putting $1.4 billion into a new drug-manufacturing campus in Durham, North Carolina, its biggest single-campus investment since the company was formed. (abbvie.com) The company said April 22 that the site will cover 185 acres and make medicines in immunology, neuroscience, and oncology. Construction is set to start in 2026, with completion expected by the end of 2028. (abbvie.com) North Carolina said the project will create 734 jobs in Durham County. Governor Josh Stein’s office said the state approved a Job Development Investment Grant valued at up to $50.8 million over 12 years, tied to hiring and investment targets. (governor.nc.gov) Drug manufacturing campuses are the factories behind pills, injections, and the chemical ingredients that go into them. A greenfield site — built from scratch on empty land — lets a company design production lines, labs, software, and automation as one system instead of retrofitting older buildings. (marketwatch.com) AbbVie said this campus will use advanced manufacturing and laboratory technology with artificial intelligence. In practice, that usually means more sensors, more automated quality checks, and software that tracks production in real time across the site. (abbvie.com) The Durham project lands as AbbVie is expanding U.S. production on multiple fronts. In February, the company announced a separate $380 million investment in North Chicago for two new active pharmaceutical ingredient facilities for neuroscience and obesity medicines. (abbvie.com) AbbVie said the North Carolina campus also counts toward its broader pledge to spend $100 billion in the United States on research and development and capital investments over the next decade. The company had previously outlined more than $10 billion of U.S. capital spending over 10 years in manufacturing expansions announced in 2025. (abbvie.com 1) (abbvie.com 2) For North Carolina, the deal adds another large drugmaker to the Research Triangle area’s life-sciences cluster. State officials said AbbVie becomes the eighth of the world’s 10 biggest pharmaceutical manufacturers with operations in North Carolina. (aol.com) The next marker is physical, not financial: breaking ground this year and getting the Durham campus ready by late 2028. That timeline will show how fast AbbVie can turn a 185-acre bet into new production capacity. (abbvie.com)